Adipose-derived autologous stem cell therapy (U.S. Stem Cell)

N/A

Report date: 2022/07/20 14:29:57

Base Information

Drug NameAdipose-derived autologous stem cell therapy (U.S. Stem Cell)
Drug Alias NameAdipoCell (Bioheart)Bioheart Acute Cell TherapyImplanted autologous adipose-derived stem cells - U.S. Stem CellLipiCell
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesU.S. Stem CellStemlab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioheart Inc
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A